Loading…
Attending this event?
Monday, June 17 • 12:55pm - 1:25pm
#124 IT: PPD, part of Thermo Fisher Scientific Innovation Theater: Accelerating Drug Development Through the Convergence of Real-World Data (RWD) and Technology

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Session

The proliferation of real-world data (RWD) sources and advancements in technology (e.g.,artificial intelligence (AI), wearables) have fueled the use of real-world evidence (RWE)in drug development. Globally diverse, trusted data sources and impactful AI and digital technologies provide faster, more comprehensive curated data for optimized study design and analysis. This intersection provides invaluable insights to help decision makers make smarter, faster decisions to advance and optimize product development.

Chair

PPD, part of Thermo Fisher Scientific

Speaker

Speaker
Peter Wahl, MS

Speaker
Ariel Berger, MPH

Speaker
Gino Pirri

Speaker
John Van Hoy, MBA



Speakers
avatar for Ariel Berger

Ariel Berger

Executive Director, Integrated Solutions, Real-World Evidence, Evidera, part of PPD clinical research business of Thermo Fisher Scientific, United States
Ariel’s focus is database analytics where he designs and advises on various RWE and health economics studies, often involving complex methodologies and hybrid designs and disciplines. He has led numerous outcomes research studies, including retrospective database analyses; developed... Read More →
avatar for John Van Hoy

John Van Hoy

Executive Director, Data Science & Advanced Analytics, PPD, part of Thermo Fisher Scientific, United States
John has been in the Life Sciences industry for nearly 20 years, with roles that span clinical trial operations, mgmt. consulting, and functional leadership. John has developed a focus on the use of data and analytics to help sponsors and CROs gain a competitive advantage. He has... Read More →
avatar for Gino Pirri

Gino Pirri

VP Head Product & Technology, PPD, part of Thermo Fisher Scientific, United States
As an executive specializing in eClinical technology, with more than 25-yrs. of experience driving innovation and advancing technology to enhance the clinical trial experience for sites and patients, Gino is at the forefront of spearheading cutting-edge advancements in digital and... Read More →
avatar for Peter Wahl

Peter Wahl

Vice President, Global Head of Scientific Affairs, CorEvitas, part of PPD clinical research business of Thermo Fisher Scientific, United States
Dr. Wahl leads scientific partnerships for Thermo Fisher multi-sponsor registries and guides strategy on new registries and leveraging RWD to support late phase/post-approval studies, including drug safety. He led programs to drive drug discovery and development, including the ClinicoGenomics... Read More →


Monday June 17, 2024 12:55pm - 1:25pm PDT
Exhibit Hall Theater #2 San Diego Convention Center 111 W Harbor Drive, San Diego, CA 92101 USA